These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26180128)

  • 1. Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions.
    Pattanawongsa A; Chau N; Rowland A; Miners JO
    Drug Metab Dispos; 2015 Oct; 43(10):1468-76. PubMed ID: 26180128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.
    Miners JO; Chau N; Rowland A; Burns K; McKinnon RA; Mackenzie PI; Tucker GT; Knights KM; Kichenadasse G
    Biochem Pharmacol; 2017 Apr; 129():85-95. PubMed ID: 28065859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202.
    Korprasertthaworn P; Chau N; Nair PC; Rowland A; Miners JO
    Biochem Pharmacol; 2019 Nov; 169():113616. PubMed ID: 31445021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
    Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
    Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cabozantinib Carries the Risk of Drug-Drug Interactions
    Wang Z; Jiang L; Wang X; Yin H; Wang Z; Lv X; Liu Y
    Curr Drug Metab; 2022; 23(11):912-919. PubMed ID: 36306450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
    Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
    Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized assays for human UDP-glucuronosyltransferase (UGT) activities: altered alamethicin concentration and utility to screen for UGT inhibitors.
    Walsky RL; Bauman JN; Bourcier K; Giddens G; Lapham K; Negahban A; Ryder TF; Obach RS; Hyland R; Goosen TC
    Drug Metab Dispos; 2012 May; 40(5):1051-65. PubMed ID: 22357286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted screen for human UDP-glucuronosyltransferases inhibitors and the evaluation of potential drug-drug interactions with zafirlukast.
    Oda S; Fujiwara R; Kutsuno Y; Fukami T; Itoh T; Yokoi T; Nakajima M
    Drug Metab Dispos; 2015 Jun; 43(6):812-8. PubMed ID: 25834030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms.
    Court MH; Duan SX; von Moltke LL; Greenblatt DJ; Patten CJ; Miners JO; Mackenzie PI
    J Pharmacol Exp Ther; 2001 Dec; 299(3):998-1006. PubMed ID: 11714888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone glucuronidation in human liver and intestine microsomes: high catalytic activity of UGT1A8 and UGT1A10.
    Watanabe Y; Nakajima M; Yokoi T
    Drug Metab Dispos; 2002 Dec; 30(12):1462-9. PubMed ID: 12433820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins.
    Barnes KJ; Rowland A; Polasek TM; Miners JO
    Eur J Clin Pharmacol; 2014 Sep; 70(9):1097-106. PubMed ID: 24954688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of fifteen phthalate esters in human cDNA-expressed UDP-glucuronosyltransferase supersomes.
    Cao YF; Du Z; Zhu ZT; Sun HZ; Fu ZW; Yang K; Liu YZ; Hu CM; Dong PP; Gonzalez FJ; Fang ZZ
    Chemosphere; 2017 Oct; 185():983-990. PubMed ID: 28753904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by darolutamide: Prediction of in vivo drug-drug interactions.
    Xiao S; Yin H; Lv X; Wang Z; Jiang L; Xia Y; Liu Y
    Chem Biol Interact; 2024 Nov; 403():111246. PubMed ID: 39278459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human UDP-Glucuronosyltransferase (UGT) 2B10: Validation of Cotinine as a Selective Probe Substrate, Inhibition by UGT Enzyme-Selective Inhibitors and Antidepressant and Antipsychotic Drugs, and Structural Determinants of Enzyme Inhibition.
    Pattanawongsa A; Nair PC; Rowland A; Miners JO
    Drug Metab Dispos; 2016 Mar; 44(3):378-88. PubMed ID: 26669329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
    Tachibana M; Tanaka M; Masubuchi Y; Horie T
    Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
    Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
    Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clotrimazole Identified as a Selective UGT2B4 Inhibitor Using Canagliflozin-2'-
    Lapham K; Ferguson N; Niosi M; Goosen TC
    Drug Metab Dispos; 2024 Sep; 52(10):1083-1093. PubMed ID: 39142826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the glucuronidation of 2-(4-chlorophenyl)- 5-(2-furyl)-4-oxazoleacetic acid (TA-1801A).
    Kaji H; Kume T
    Drug Metab Pharmacokinet; 2005 Jun; 20(3):212-8. PubMed ID: 15988124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.